56 related articles for article (PubMed ID: 14567679)
1. The G protein-coupled receptor GPR4 suppresses ERK activation in a ligand-independent manner.
Bektas M; Barak LS; Jolly PS; Liu H; Lynch KR; Lacana E; Suhr KB; Milstien S; Spiegel S
Biochemistry; 2003 Oct; 42(42):12181-91. PubMed ID: 14567679
[TBL] [Abstract][Full Text] [Related]
2. CNS distribution, signalling properties and central effects of G-protein coupled receptor 4.
Hosford PS; Mosienko V; Kishi K; Jurisic G; Seuwen K; Kinzel B; Ludwig MG; Wells JA; Christie IN; Koolen L; Abdala AP; Liu BH; Gourine AV; Teschemacher AG; Kasparov S
Neuropharmacology; 2018 Aug; 138():381-392. PubMed ID: 29894771
[TBL] [Abstract][Full Text] [Related]
3. Lysophospholipid G protein-coupled receptor binding parameters as determined by backscattering interferometry.
Mizuno H; Kihara Y; Kussrow A; Chen A; Ray M; Rivera R; Bornhop DJ; Chun J
J Lipid Res; 2019 Jan; 60(1):212-217. PubMed ID: 30463988
[TBL] [Abstract][Full Text] [Related]
4. pH Dependence of a GPR4 Selective Antagonist Hampers Its Therapeutic Potential.
Stalewski J; Shih AY; Papazyan R; Ramirez J; Ibanez G; Hsiao P; Yue Y; Yin J; Badger C; Wu S; Ueki A; Fuchs BC; Rives ML
J Pharmacol Exp Ther; 2023 Jul; 386(1):35-44. PubMed ID: 37142444
[TBL] [Abstract][Full Text] [Related]
5. Expression of endogenous epitope-tagged GPR4 in the mouse brain.
Gonye EC; Dagli AV; Kumar NN; Clements RT; Xu W; Bayliss DA
eNeuro; 2024 Feb; 11(3):. PubMed ID: 38408869
[TBL] [Abstract][Full Text] [Related]
6. GPR31 and GPR151 are activated under acidic conditions.
Mashiko M; Kurosawa A; Tani Y; Tsuji T; Takeda S
J Biochem; 2019 Oct; 166(4):317-322. PubMed ID: 31119277
[TBL] [Abstract][Full Text] [Related]
7. Vascular abnormalities in mice deficient for the G protein-coupled receptor GPR4 that functions as a pH sensor.
Yang LV; Radu CG; Roy M; Lee S; McLaughlin J; Teitell MA; Iruela-Arispe ML; Witte ON
Mol Cell Biol; 2007 Feb; 27(4):1334-47. PubMed ID: 17145776
[TBL] [Abstract][Full Text] [Related]
8. Differential Roles of Extracellular Histidine Residues of GPR68 for Proton-Sensing and Allosteric Modulation by Divalent Metal Ions.
Huang XP; Kenakin TP; Gu S; Shoichet BK; Roth BL
Biochemistry; 2020 Sep; 59(38):3594-3614. PubMed ID: 32865988
[TBL] [Abstract][Full Text] [Related]
9. An Updated Review of Pro- and Anti-Inflammatory Properties of Plasma Lysophosphatidylcholines in the Vascular System.
Knuplez E; Marsche G
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599910
[TBL] [Abstract][Full Text] [Related]
10. A novel sphingosylphosphorylcholine and sphingosine-1-phosphate receptor 1 antagonist, KRO-105714, for alleviating atopic dermatitis.
Yoon SB; Lee CH; Kim HY; Jeong D; Jeon MK; Cho SA; Kim K; Lee T; Yang JY; Gong YD; Cho H
J Inflamm (Lond); 2020; 17():20. PubMed ID: 32514255
[TBL] [Abstract][Full Text] [Related]
11. Role of Sphingosylphosphorylcholine in Tumor and Tumor Microenvironment.
Park MK; Lee CH
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31683697
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide screening identifies novel genes implicated in cellular sensitivity to BRAF
Ko T; Sharma R; Li S
Oncogene; 2020 Jan; 39(4):723-738. PubMed ID: 31548614
[TBL] [Abstract][Full Text] [Related]
13. GPR35 mediates lodoxamide-induced migration inhibitory response but not CXCL17-induced migration stimulatory response in THP-1 cells; is GPR35 a receptor for CXCL17?
Park SJ; Lee SJ; Nam SY; Im DS
Br J Pharmacol; 2018 Jan; 175(1):154-161. PubMed ID: 29068046
[TBL] [Abstract][Full Text] [Related]
14. RNAi targeting GPR4 influences HMEC-1 gene expression by microarray analysis.
Ren J; Zhang Y; Cai H; Ma H; Zhao D; Zhang X; Li Z; Wang S; Wang J; Liu R; Li Y; Qian J; Wei H; Niu L; Liu Y; Xiao L; Ding M; Jiang S
Int J Clin Exp Med; 2014; 7(3):607-15. PubMed ID: 24753754
[TBL] [Abstract][Full Text] [Related]
15. Activation of GPR4 by acidosis increases endothelial cell adhesion through the cAMP/Epac pathway.
Chen A; Dong L; Leffler NR; Asch AS; Witte ON; Yang LV
PLoS One; 2011; 6(11):e27586. PubMed ID: 22110680
[TBL] [Abstract][Full Text] [Related]
16. Acyl chain-dependent effect of lysophosphatidylcholine on endothelial prostacyclin production.
Riederer M; Ojala PJ; Hrzenjak A; Graier WF; Malli R; Tritscher M; Hermansson M; Watzer B; Schweer H; Desoye G; Heinemann A; Frank S
J Lipid Res; 2010 Oct; 51(10):2957-66. PubMed ID: 20610733
[TBL] [Abstract][Full Text] [Related]
17. Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor.
Dyer KD; Percopo CM; Xie Z; Yang Z; Kim JD; Davoine F; Lacy P; Druey KM; Moqbel R; Rosenberg HF
J Immunol; 2010 Jun; 184(11):6327-34. PubMed ID: 20421642
[TBL] [Abstract][Full Text] [Related]
18. Activation of mitogen-activated protein kinases by lysophosphatidylcholine-induced mitochondrial reactive oxygen species generation in endothelial cells.
Watanabe N; Zmijewski JW; Takabe W; Umezu-Goto M; Le Goffe C; Sekine A; Landar A; Watanabe A; Aoki J; Arai H; Kodama T; Murphy MP; Kalyanaraman R; Darley-Usmar VM; Noguchi N
Am J Pathol; 2006 May; 168(5):1737-48. PubMed ID: 16651638
[TBL] [Abstract][Full Text] [Related]
19. Sphingolipids differentially regulate mitogen-activated protein kinases and intracellular Ca2+ in vascular smooth muscle: effects on CREB activation.
Mathieson FA; Nixon GF
Br J Pharmacol; 2006 Feb; 147(4):351-9. PubMed ID: 16402047
[TBL] [Abstract][Full Text] [Related]
20. Genomic profiling of mixer and Sox17beta targets during Xenopus endoderm development.
Dickinson K; Leonard J; Baker JC
Dev Dyn; 2006 Feb; 235(2):368-81. PubMed ID: 16278889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
